Perioperative immunomodulation with interleukin-2 in patients with renal cell carcinoma: results of a controlled phase II trial

We conducted a non-randomised controlled phase II trial to investigate the role of preoperative administration of interleukin-2 (IL-2) in patients with renal cell carcinoma undergoing tumour nephrectomy. A total of 120 consecutive patients were allocated alternately to the two study groups: perioper...

Descripción completa

Detalles Bibliográficos
Autores principales: Klatte, T, Ittenson, A, Röhl, F-W, Ecke, M, Allhoff, E P, Böhm, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360567/
https://www.ncbi.nlm.nih.gov/pubmed/17031403
http://dx.doi.org/10.1038/sj.bjc.6603391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360567/
https://www.ncbi.nlm.nih.gov/pubmed/17031403
http://dx.doi.org/10.1038/sj.bjc.6603391

Ejemplares similares